Patent · US Active

Mechanism to signal receptor-ligand interactions with luminescent quantum dots

US8198099B2 · kind B2 · utility

1Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 9, 2007
Grant dateJun 12, 2012
Priority date
Expiry dateOct 21, 2028

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S436/805
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Semiconductor quantum dots are becoming valuable analytical tools for use in biomedical applications. Indeed, their unique properties offer the opportunity to design luminescent probes for imaging and sensing with unprecedented performance. In this context, we have identified operating principles to transduce supramolecular association of complementary receptor-ligand binding pairs into enhancement or suppression in the luminescence of sensitive quantum dots. Thus, complementary receptor-ligand binding pairs can be identified with luminescence measurements relying on our design logic. In fact, we have demonstrated with a representative example that our protocol can be adapted to signal receptor-ligand binding.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.